Share Name Share Symbol Market Type Share ISIN Share Description
Fevertree Drk LSE:FEVR London Ordinary Share GB00BRJ9BJ26 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +25.00p +2.41% 1,062.00p 1,059.00p 1,062.00p 1,065.00p 1,039.00p 1,040.00p 77,143.00 11:24:37
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Beverages 59.3 16.8 11.6 91.8 1,223.86

Fevertree Drk (FEVR) Latest News

More Fevertree Drk News
Fevertree Drk Takeover Rumours

Fevertree Drk (FEVR) Share Charts

1 Year Fevertree Drk Chart

1 Year Fevertree Drk Chart

1 Month Fevertree Drk Chart

1 Month Fevertree Drk Chart

Intraday Fevertree Drk Chart

Intraday Fevertree Drk Chart

Fevertree Drk (FEVR) Discussions and Chat

Fevertree Drk Forums and Chat

Date Time Title Posts
08/12/201615:10FEVER TREE with chart91.00
01/12/201615:25Fevertree Drinks PLC (Fever-Tree)765.00
07/11/201423:50Is Fever Tree fairly Valued?-

Add a New Thread

Fevertree Drk (FEVR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:24:371,062.001091,157.58AT
11:24:371,061.001671,771.87AT
11:24:371,061.0032339.52AT
11:24:371,061.0080848.80AT
11:24:371,061.00774.27AT
View all Fevertree Drk trades in real-time

Fevertree Drk (FEVR) Top Chat Posts

DateSubject
09/12/2016
08:20
Fevertree Drk Daily Update: Fevertree Drk is listed in the Beverages sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree Drk was 1,037p.
Fevertree Drk has a 4 week average price of 1,051.05p and a 12 week average price of 1,006.02p.
The 1 year high share price is 1,121p while the 1 year low share price is currently 487p.
There are currently 115,240,896 shares in issue and the average daily traded volume is 265,694 shares. The market capitalisation of Fevertree Drk is £1,223,858,315.52.
28/10/2016
15:38
terry topper: scantrader I have followed this company very closely from flotation and every announcement, including the final 2015 results, has been better than expected. I'm sure you would agree that there is no way that the share price would have performed as it has if there had been even a hint of failing to meet expectations I am not disputing what your link shows..... but I think there is something funny affecting it - I think it must be due to the way Cenkos are calculating eps. Cenkos initiated coverage on 4 Nov 2015 with a forecast for y/e 2015 of 9.6p eps. They then upgraded after the year end update to 11.9p (described as adjusted diluted). Their most recent note, from July 2016, shows 2015 actual eps as 12.2p compared to the figure reported by the company of 11.48p. I don't have time just now but will try to look into it later - I am intrigued now myself!
10/8/2016
20:18
topvest: I agree with you. It's a fabulous company. However, the share price is ridiculous. Buying at this level would be a serious error. You will need to get off before something nasty happens....it's priced at perfection and more...that always ends badly. Indeed they have already warned that UK growth can't continue at the rate it has been which stands to reason as tonic water can only sell so much.
26/7/2016
09:38
leedskier: Market Cap is quickly approaching £1bn, which is impressive for a niche company making and selling mixers for gin.But since it is one of those shares which few would even contemplate shorting, I guess it's m.c. could just keep on keeping on, as the company keeps growing it's sales or is taken over.Congratulations to those who had the wisdom to buy when it's share price was significantly lower.
26/7/2016
06:49
bookbroker: These look vulnerable, share price already reflecting strong growth, they will new products to drive growth, as I've said before it's the alcohol rather than the mixer I prefer, however if it's soft drinks you like then this co. will have to introduce a new, larger compliment of products, I am not off the belief you have to spend so much on an improved mixer, never had an issue with Schweppes tonic water!
27/5/2016
13:52
darryn1: An aptly named company. The market certainly has a fever on this with the share price more than quadrupling over the last 18 months. Annual sales of £60m, net cash of £12m, PE of over 60 and a market capitalisation of £820m. A crazy valuation which could make this a fantastic shorting opportunity in due course.
24/3/2016
11:43
greek islander: Interesting, but we will see some seriou selling as the share price surges and big shareholders take profits. Considering the sales the share price held up well over the last few days. The share price looks heading for a high point in the near future. I find that my portfolio needs a FEVR in there to counteract the movement elsewhere. I find that in bad days and good days it goes against the general trend. Fever Tree products are more than just tonic and as customers realise it and move on to other mixers etc we should see that the revenue relies less on its figurehead product.
16/3/2016
18:03
bostonborn: Found a transcript of the Tempus article: Business is booming at Fever-Tree and there is room for further growth, but trading on 40 times' this year's earnings the valuation looks toppy, The Times's Tempus said. The maker of premium mixers for spirits already controls nearly half the market, which is estimated to be worth between £300m to £400m and might be set to reach about £1.6bn, according to EY. Floating at 134p in November 2014 those who got in early enjoyed a ride all the way up to a peak of 694p this year. For the full year the company reported "pretty staggering" margins of 52.1%, aided by its 'investment-light' model and it has signed up another retailer, Marks&Spencer, to its distribution network. That is key for future growth, increasing its footprint in the on-trade and opening the doors to the Australian market where sales rocketed 77% last year. Nonetheless, the shares' price-to-earnings multiple looks 'high' "and lucky investors should think about taking profits", Tempus said. "Take profits, the current rate of growth cannot be expected to continue" the tipster concluded. Hope this helps!! My view is that long term, perhaps in 5 years time; a takeover may happen but only if the share price 'collapsed' i.e. a PE ratio of say 20.
16/3/2016
12:11
greek islander: Everyone worries about the high PE level and it is a factor in deciding whether to buy. However, for a company that is relatively newly listed and one that is enjoying a boom in revenue levels this is not by any means out of the ordinary. It still is a modest PE compared with the early days of ASOS when the PE and the share price continued to rise dramatically for a while before it hit the wall. I can see continued revenue rises though inevitably the growth rate will eventually slow down and level off. However, this is a vibrant management with expansive momentum and is a fair bet for a further dramatic share price rise in the immediate future. I rate it still very much a buy!
14/3/2016
07:14
silverfern: 8 Mar'16 - 17:13 - 527 of 555 "DOse of reality more like- eps of 10-12p give a p/e of 40-50"....ANd that is the reality this morning with an eps of 11.5p and profits of £13m. GReat performance to increase the eps as it has but the current share price factors in further exponential growth imho.
09/3/2016
14:46
family values: Nice to see a return to a rocketing share price. I wouldn't read too much into this yet. I firmly believe the large buys ahead of results have yet to appear. All sorts of spread bets and CFDs working their way through the system. Friday pm, that's when the fireworks will really start.
Fevertree Drk share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20161209 11:40:36